Aptuit Names Vito Saccente Senior Director, Sales for North America; Strategic Hire Strengthens Company's Sales Force and U.S. Presence.

GREENWICH, Conn. -- Aptuit, Inc. announced today that Vito G. Saccente has been appointed Senior Director, Sales for the North American regional network of its global drug development services enterprise. Mr. Saccente has nearly 20 years of industry experience, possessing an in-depth knowledge of the drug development landscape including inside sales, sales management, and business development for companies ranging from drug wholesalers to large pharmaceutical services businesses. Mr. Saccente will manage Aptuit's North American sales force, work to expand its client base, and further the company's dedication to delivering top-tier customer service.

"As part of our effort to engineer a better drug development process, we offer customers a series of overlapping service modules spanning the entire drug development continuum, giving clients the option to choose a tailored group of modules or an end-to-end solution. Vito brings the industry expertise and management skills needed to provide valuable insight into our unique service model and help customers choose the best option for their project," said Kurt Mussina, Vice President, Sales and Marketing at Aptuit. "Our ability to streamline the drug development process for customers, from our very first interaction, speaks to our commitment to breaking down the traditional silos of drug development and providing true value for customers. Vito's hire furthers Aptuit's ability to meet the varying needs of our customers."

Aptuit is a world leader in drug development services, with revenues in 2006 expected to exceed $250M and over $750M in private funding available. Aptuit offers a full spectrum of drug development services, from active pharmaceutical ingredient development to clinical packaging and logistics, and continues to explore new opportunities to add depth to its current business lines. As Senior Director, Sales for North America, Mr. Saccente will provide sound leadership to the existing North American sales team and actively work to recruit recognized industry experts to expand the company's sales efforts.

"Aptuit is setting the industry standard for contract drug development services, offering horizontal management across service modules and technologic capabilities that truly streamline the entire drug development process for customers," noted Mr. Saccente. "The company has experienced significant growth and several strategic acquisitions over the last year and now provides a broad range of top-tier services to more than 250 pharmaceutical and biotechnology companies worldwide. Today's drug development sector is extremely milestone-driven and Aptuit is committed to achieving these critical milestones alongside customers."

Prior to joining Aptuit, Mr. Saccente was at AAI Pharma for eight years, most recently serving as Director, National Sales, where he managed all aspects of its U.S. product development sales team and was responsible for a $50M sales quota. Mr. Saccente also served as a regional manager of sales and area manager of business development in his tenure at AAI, continually exceeding revenue goals. In addition, Mr. Saccente was formerly Business Development Manager at Cardinal Health.

Prior to Cardinal Health, Mr. Saccente served in a variety of positions, ranging from sales training to Director of sales operations, at Neuman Distributions, a drug wholesale operations company. Mr. Saccente holds a business administration and marketing degree from Monmouth College.

About Aptuit:

Aptuit, Inc. is a global company focused on streamlining and supporting the drug development process for biotechnology and pharmaceutical innovators. The company was founded by a group of industry experts with extensive market experience who have a track record of building a similar, highly successful company through acquisitions and investment. Aptuit provides a comprehensive suite of product development services and competencies to biotechnology companies and large, fully integrated pharmaceutical companies worldwide. Currently, the company has more than 2,100 employees, 12 global facilities, and resources to reach 70 countries. Aptuit's mission is to engineer a better drug development process, and is partnered with Welsh, Carson, Anderson & Stowe, one of the world's largest private equity investors. For more information about Aptuit, please visit http://www.aptuit.com.